Nurix Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $48k | 4.6k | 10.32 |
| 2023-09-30 | $36k | 4.6k | 7.86 |
| 2023-06-30 | $33k | 3.3k | 9.99 |
| 2023-03-31 | $30k | 3.3k | 8.88 |
| 2022-12-31 | $42k | 3.3k | 12.65 |
| 2022-09-30 | $43k | 3.3k | 12.93 |
| 2022-06-30 | $42k | 3.3k | 12.63 |
| 2022-03-31 | $34k | 2.5k | 13.84 |
| 2021-12-31 | $71k | 2.5k | 28.91 |
| 2021-09-30 | $74k | 2.5k | 30.13 |
| 2021-06-30 | $65k | 2.5k | 26.47 |
| 2021-03-31 | $61k | 1.9k | 31.33 |
| 2020-12-31 | $31k | 946 | 32.77 |
| 2020-09-30 | $33k | 946 | 34.88 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors